Home / Market News / $SBRA
benzinga Corporate Catalyst Impact 75/100 ● neutral

Sabra Sees FY26 Net Income Of $0.37-$0.39, FFO Of $1.12-$1.14, Normalized FFO Of $1.53-$1.55, AFFO Of $1.58-$1.60 And Normalized AFFO Of $1.59-$1.61

Jul 21, 2026, 1:09 PM UTC · Primary ticker $SBRA

Sabra Health Care REIT has significantly updated its 2026 financial guidance upwards, driven by successful re-tenanting of its Avamere portfolio and a favorable mortgage repayment. This indicates improved operational efficiency and financial health, likely leading to a positive market reaction for SBRA.

Sabra Health Care REIT announced a significant business update, including the successful re-tenanting of 26 properties previously leased to Avamere, resulting in a nearly 30% increase in annualized cash rent. Additionally, Sabra agreed to a reduced cash repayment of a $300 million mortgage for $200 million, improving its Net Debt to EBITDA ratio and reducing behavioral health concentration. These strategic moves have led to an upward revision of full-year 2026 guidance for Net Income, FFO, Normalized FFO, AFFO, and Normalized AFFO. This is a positive development for SBRA, indicating improved financial stability and operational performance, which should be well-received by investors in the short term. The long-term implications suggest a more robust and diversified portfolio with stronger cash flow generation.

$SBRA positive Increased guidance and improved financial metrics
$ENR neutral Cascadia Healthcare CEO previously worked for Ensign Group subsidiary
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.